Vitamin A Deficiency – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032
Vitamin A is a lipid-soluble micronutrient that plays a vital role in cellular development, metabolism, immune function, vision, and reproductive processes. Insufficient intake or absorption of vitamin A can lead to a deficiency, impairing important physiological functions. Vitamin A deficiency (VAD) is a widespread health concern affecting young children and is associated with significant morbidity and mortality. According to the Institute of Medicine, the recommended dietary allowance (RDA) of vitamin A for healthy adults is 700 micrograms/day for women and 900 micrograms/day for men. Children, pregnant women, and lactating women have different RDAs, which are 300 to 900, 770, and 1300 micrograms/day, respectively. Ocular symptoms related to vitamin A deficiency have been observed to occur when blood concentrations are lower than 10 micrograms/dL. Inadequate nutrition compounded by chronic inflammation resulting from regular gastrointestinal (GI) infections is the primary cause of vitamin A deficiency. This situation often leads to multiple micronutrient deficiencies. Vitamin A is crucial for regenerating visual pigments, maintaining mucosal membranes, and proper immune function. Insufficient vitamin A levels can cause night blindness due to impaired regeneration of visual pigments in retinal rods. If the deficiency persists, the retinal rods will degenerate, leading to a condition called xerophthalmia, which can result in permanent blindness. Insufficient vitamin A also leads to dryness and breakdown of the mucosal membranes in the intestines and lungs, along with compromised immune function, resulting in frequent infections and anemia caused by chronic inflammation. The recommended treatment for vitamin A deficiency is vitamin A supplementation. The prognosis of vitamin A deficiency depends on the severity of the disease when treatment is initiated. Severe vitamin A deficiency may lead to irreversible vision loss or blindness, heightened susceptibility to infections, and impaired immune function, significantly increasing mortality rates.
·
In the USA, vitamin A deficiency is rare and
estimated to affect only 0.3% of individuals. Conversely, the prevalence of
vitamin A toxicity in the US is much higher than that of deficiency.
Thelansis’s “Vitamin A Deficiency
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report
– 2022 To 2032" covers disease overview, epidemiology, drug utilization,
prescription share analysis, competitive landscape, clinical practice,
regulatory landscape, patient share, market uptake, market forecast, and key
market insights under the potential Vitamin A Deficiency treatment modalities
options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan,
and China).
KOLs insights
of Vitamin A Deficiency across 8 MM market from the centre of Excellence/
Public/ Private hospitals participated in the study. Insights around current
treatment landscape, epidemiology, clinical characteristics, future treatment
paradigm, and Unmet needs.
Vitamin A Deficiency Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment